Skip to main content
padlock icon - secure page this page is secure

Copper-Doped Mesoporous Bioactive Glass for Photothermal Enhanced Chemotherapy

Buy Article:

$106.81 + tax (Refund Policy)

The current therapy for bone tumor is difficult to eliminate tumor cells completely and often leads to bone defects and other side effects. To achieve optimal bone tumor therapeutic effect, a dual functional material with tumor therapy and bone regeneration is required. Herein, we successfully synthesized copper-doped mesoporous bioactive glasses that has both photothermal effect and bone-forming bioactivity. The copper-doped mesoporous bioactive glasses has both excellent drug loading capacity and photothermal property, and the drug release could be well modulated by the photothermal effect. The experiment in vitro showed that copper-doped mesoporous bioactive glasses possessed the ability of a combination of photothermal therapy and chemotherapy to enhance the tumor therapy. In addition, the synthesized copper-doped mesoporous bioactive glasses has good bioactivity for inducing the formation of apatite mineralization. Such dual functional materials present remarkable tumor therapy ability and bone bioactivity, offering new strategy for bone tumor therapy.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: BONE TUMOR; COMBINE THERAPY; COPPER; DOXORUBICIN HYDROCHLORIDE; MESOPOROUS BIOACTIVE GLASS; PHOTOTHERMAL EFFECT

Document Type: Research Article

Publication date: April 1, 2018

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more